Case number 1:22-cv-00523
Astellas US LLC et al v. GE Healthcare Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 3, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (8 in 1:22-cv-00523-CFC) MOTION to Consolidate Cases / GE Healthcare's Unopposed Motion to Consolidate filed by GE Healthcare Inc. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 21-1785-CFC ONLY. Ordered by Judge Colm F. Connolly on 6/3/2022. Associated Cases: 1:22-cv-00523-CFC, 1:21-cv-01785-CFC(nmf) |
| Jun 3, 2022 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:21-cv-01785-CFC. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 21-1785-CFC ONLY. (nmf) |
| Jun 2, 2022 | 8 | Main Document (7) Docket Text: MOTION to Consolidate Cases / GE Healthcare's Unopposed Motion to Consolidate - filed by GE Healthcare Inc.. (Attachments: # (1) [Proposed] Order to Consolidate)(Brauerman, Stephen) |
| Jun 2, 2022 | 8 | [Proposed] Order to Consolidate (3) |
| May 13, 2022 | 7 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Astellas US LLC, Gilead Sciences, Inc., Astellas Pharma US, Inc.: For GE Healthcare Inc. waiver sent on 4/27/2022, answer due 6/27/2022. (Del Dotto, Kelly) |
| Apr 27, 2022 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Apr 25, 2022 | N/A | No Summons Issued (0) Docket Text: No Summons Issued. (mpb) |
| Apr 25, 2022 | 1 | Main Document (12) Docket Text: COMPLAINT filed against GE Healthcare Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3858468.) - filed by Astellas US LLC, Gilead Sciences, Inc., Astellas Pharma US, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Civil Cover Sheet)(mpb) |
| Apr 25, 2022 | 1 | Exhibit A (22) |
| Apr 25, 2022 | 1 | Exhibit B (22) |
| Apr 25, 2022 | 1 | Exhibit C (20) |
| Apr 25, 2022 | 1 | Exhibit D (18) |
| Apr 25, 2022 | 1 | Civil Cover Sheet (1) |
| Apr 25, 2022 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) |
| Apr 25, 2022 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 03/16/2022. Date of Expiration of Patent: 02/02/2027.Thirty Month Stay Deadline: 9/16/2024. (mpb) |
| Apr 25, 2022 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,106,183 ;US RE 47,301 E ;US 8,524,883. (mpb) |
| Apr 25, 2022 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Astellas Pharma Inc., Corporate Parent Astellas US Holding, Inc. for Astellas Pharma US, Inc., Astellas US LLC filed by Astellas Pharma US, Inc., Astellas US LLC. (mpb) |
| Apr 25, 2022 | 6 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Gilead Sciences, Inc.. (mpb) |
| Apr 25, 2022 | 1 | Complaint* (1) |
